Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Constance A Benson

Showing results (21-30 of 104) with videos related to

Pageof 11
Sort By:
JMIR Research Protocols|September 9, 2020
The Role of Stress and Genital Immunity in Sexual Trauma and HIV Susceptibility Among Adolescent Girls and Adult Women (The THRIVE Study): Protocol for a Longitudinal Case-Control StudyJamila K Stockman, Katherine M Anderson, Maile Y Karris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2021
Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis CoinfectionMichelle A Kendall, Umesh Lalloo, Courtney V Fletcher, et al.
Cytometry. Part B, Clinical Cytometry|April 29, 2015
Near patient CD4 count in a hospitalized HIV patient populationMonique Givens, Amanda Weaver, Sarah Bickman, et al.
EC Microbiology|January 17, 2023
Coinfection of HIV-1 with <i>Schistosoma</i> spp. and with Intestinal Parasites in Patients Attending Boane Health Center, Maputo Province, MozambiqueLucas Banze, Ana Carina Madureira, Borges Cerveja Zacarias, et al.
BMC Infectious Diseases|April 21, 2023
Susceptibility antibiotic screening reveals high rates of multidrug resistance of Salmonella, Shigella and Campylobacter in HIV infected and uninfected patients from MozambiqueDelfina F Hlashwayo, Emília V Noormahomed, Leonilde Bahule, et al.
Clinical and Vaccine Immunology : CVI|April 11, 2008
Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapyCara C Wilson, Mark J Newman, Brian D Livingston, et al.
Oncology|May 25, 2011
Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysisSupriya Krishnan, Jeffrey T Schouten, Denise L Jacobson, et al.
Annals of Global Health|March 16, 2019
The Medical Education Partnership Initiative Effect on Increasing Health Professions Education and Research Capacity in MozambiqueEmília Virgínia Noormahomed, Ana Olga Mocumbi, Mamudo Ismail, et al.
AIDS (London, England)|December 12, 2013
The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapyJudith J Lok, Peter W Hunt, Ann C Collier, et al.
Plos Medicine|October 5, 2019
Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trialSara H Browne, Anya Umlauf, Amanda J Tucker, et al.
Pageof 11

Showing results (21-30 of 104) with videos related to

Sort By:
Pageof 11
JMIR Research Protocols|September 9, 2020
The Role of Stress and Genital Immunity in Sexual Trauma and HIV Susceptibility Among Adolescent Girls and Adult Women (The THRIVE Study): Protocol for a Longitudinal Case-Control StudyJamila K Stockman, Katherine M Anderson, Maile Y Karris, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 16, 2021
Safety and Pharmacokinetics of Double-Dose Lopinavir/Ritonavir + Rifampin Versus Lopinavir/Ritonavir + Daily Rifabutin for Treatment of Human Immunodeficiency Virus-Tuberculosis CoinfectionMichelle A Kendall, Umesh Lalloo, Courtney V Fletcher, et al.
Cytometry. Part B, Clinical Cytometry|April 29, 2015
Near patient CD4 count in a hospitalized HIV patient populationMonique Givens, Amanda Weaver, Sarah Bickman, et al.
EC Microbiology|January 17, 2023
Coinfection of HIV-1 with <i>Schistosoma</i> spp. and with Intestinal Parasites in Patients Attending Boane Health Center, Maputo Province, MozambiqueLucas Banze, Ana Carina Madureira, Borges Cerveja Zacarias, et al.
BMC Infectious Diseases|April 21, 2023
Susceptibility antibiotic screening reveals high rates of multidrug resistance of Salmonella, Shigella and Campylobacter in HIV infected and uninfected patients from MozambiqueDelfina F Hlashwayo, Emília V Noormahomed, Leonilde Bahule, et al.
Clinical and Vaccine Immunology : CVI|April 11, 2008
Clinical phase 1 testing of the safety and immunogenicity of an epitope-based DNA vaccine in human immunodeficiency virus type 1-infected subjects receiving highly active antiretroviral therapyCara C Wilson, Mark J Newman, Brian D Livingston, et al.
Oncology|May 25, 2011
Incidence of non-AIDS-defining cancer in antiretroviral treatment-naïve subjects after antiretroviral treatment initiation: an ACTG longitudinal linked randomized trials analysisSupriya Krishnan, Jeffrey T Schouten, Denise L Jacobson, et al.
Annals of Global Health|March 16, 2019
The Medical Education Partnership Initiative Effect on Increasing Health Professions Education and Research Capacity in MozambiqueEmília Virgínia Noormahomed, Ana Olga Mocumbi, Mamudo Ismail, et al.
AIDS (London, England)|December 12, 2013
The impact of age on the prognostic capacity of CD8+ T-cell activation during suppressive antiretroviral therapyJudith J Lok, Peter W Hunt, Ann C Collier, et al.
Plos Medicine|October 5, 2019
Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trialSara H Browne, Anya Umlauf, Amanda J Tucker, et al.
Pageof 11